VTCN1 and acute myeloid leukemia: These results strongly indicate that B7-H4 may act as a tumor suppressor specifically for AML and does not affect functions of hematopoietic stem cells as we previously described,10 which suggests that B7-H4 may be an ideal target for the elimination of LICs.